The rs72613567: TA Variant in the Hydroxysteroid 17-beta Dehydrogenase 13 Gene Reduces Liver Damage in Obese Children.

doi:10.1097/MPG.0000000000002573

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The rs72613567: TA Variant in the Hydroxysteroid 17-beta Dehydrogenase 13 Gene Reduces Liver Damage in Obese Children.

Journal of pediatric gastroenterology and nutrition - 1 Mar 2020

Di Sessa Anna, Umano Giuseppina Rosaria, Cirillo Grazia, Marzuillo Pierluigi, Arienzo Maria Rosaria, Pedullà Marcella, Miraglia Del Giudice Emanuele

Abstract excerpt

We first investigated in obese children the protective role of the hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) rs72613567:TA variant in liver damage. Six hundred eighty-five obese children were genotyped for HSD17B13, patatin-like phospholipase domain containing 3 (PNPLA3), transmembrane 6 superfamily member 2 (TM6SF2), and membrane bound O-acyltransferase domain containing 7 (MBOAT7) polymorphisms and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 17-Hydroxysteroid Dehydrogenases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child

Share to Genetic Predisposition to Disease

Share to Liver

Share to Non-alcoholic Fatty Liver Disease

Share to Obesity

Share to Oxidoreductases

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed

Identifiers

PMID: 31789772
DOI: 10.1097/MPG.0000000000002573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The rs72613567: TA Variant in the Hydroxysteroid 17-beta Dehydrogenase 13 Gene Reduces Liver Damage in Obese Children.PMID 31789772Read ↗

Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanismsSemantic proximity Read ↗

Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant.Semantic proximity Read ↗

MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery.Semantic proximity Read ↗

PARVB and HSD17B13 variants are associated with nonalcoholic fatty liver disease in children.Semantic proximity Read ↗

Genetic variation of HSD17B13 is associated with an increased risk of lean nonalcoholic fatty liver diseaseSemantic proximity Read ↗

The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.Semantic proximity Read ↗

Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic TargetSemantic proximity Read ↗

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension.Semantic proximity Read ↗

Genetic variant rs72613567 of HSD17B13 gene reduces alcohol-related liver disease risk in Chinese Han population.Semantic proximity Read ↗

High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase–Lowering Effect of a HSD17B13 VariantSemantic proximity Read ↗

Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis.Semantic proximity Read ↗

Genetic variation and elevated liver enzymes during childhood, adolescence and early adulthood.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.